A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
A major new NIHR funded programme grant aims to make medical implants safer and better value for money in the NHS. The project will develop a robust framework to assess the long-term risks, benefits and costs of implants.
A team from the University of Oxford and Oxford Health NHS Foundation Trust created a therapeutic horticulture garden in a psychiatric intensive care unit for young people, as part of a new study looking at how green spaces can benefit patients and staff.
A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, \u201899mTc-maraciclatide\u2019, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
A new study by Tommy\u2019s researchers, led by Professor Arri Coomarasamy, from the Nuffield Department of Women\u2019s & Reproductive Health, suggests that offering follow-up care from the first miscarriage could help prevent around 10,000 pregnancy losses each year in the UK.
Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.
A new study led by researchers at the University of Oxford demonstrates that the huge success of effective antiretroviral therapy (ART) against HIV could have altered the course of human evolution.
Professor Samira Lakhal-Littleton from the Department of Physiology, Anatomy and Genetics is part of a team of international collaborators awarded 15 million euros, including 2.6 million euros to Oxford, from the European Research Council.
Researchers from the Department of Oncology are part of a \u20ac50 million European project looking at how innovative medical and digital technologies can improve the early detection of heart-related problems in cancer patients and survivors.
New data published today in the European Society for Medical Oncology (ESMO) Real World Data and Digital Oncology show that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.
The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world\u2019s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.
Oxford University researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson\u2019s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.
Malaria is one of the world\u2019s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.
A major international study led by researchers at the Nuffield Dept of Women's & Reproductive Health, University of Oxford has found that lowering blood pressure reduces the risk of cardiovascular disease by approximately 9\u201310% for every 5 mm Hg reduction in systolic blood pressure with consistent benefits across all stages of chronic kidney disease (CKD).
The PANORAMIC trial, led from Oxford's Nuffield Department of Primary Care Health Sciences, finds that Paxlovid speeds COVID-19 recovery but does not reduce hospitalisations or deaths in vaccinated higher-risk adults. Published alongside Canada's CanTreatCOVID trial in the New England Journal of Medicine.
Despite the NHS adding roughly 250,000 staff between 2018 and 2023, elective surgery waiting lists kept growing. New research analysing 132 NHS Trusts finds that staff sickness absence and unstable administrative teams \u2013 not workforce size \u2013 are key factors.
New data reveals that 104 children in England have died between April 2019 and 3 December 2024 with temporary accommodation identified as a contributing factor to their vulnerability, ill health or death.
![\"A](\"https://www.medsci.ox.ac.uk/news/new-study-improves-early-detection-of-life-threatening-infection-in-children-across-south-and-south-east-asia/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n